Search your stocks

Share

Profile

ONESOURCEOnesource Specialty Pharma Ltd.

1841.8(-0.97%)

1W: +1.20%

1M: -1.88%

1Y: +%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Consistent revenue growth over the past three quarters indicates strong demand for products.
Improved profit margins signal enhanced operational efficiency and cost management.
Successful product launches have contributed to increased market share and brand recognition.

NEGATIVES

Declining net income in the latest quarter raises concerns about profitability sustainability.
Rising raw material costs may pressure margins in future quarters.
Increased competition within the manufacturing sector could impact sales growth.

Quarterly Results Data

Field	Trend	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		67.98	392.56	425.95	327.27
Expenses		107.64	363.94	345.34	334.07
Operating Profit		-39.66	28.63	80.61	-6.80
Other Income		0.58	5.39	2.89	5.27
Interest		20.73	45.82	33.41	27.48
Depreciation		19.06	68.77	68.49	67.80
Profit Before Tax		-39.08	-66.50	83.50	-4.40
Tax		0	2.35	-15.69	-4.21
Net Profit		-39.08	-68.85	98.50	-0.19
Eps in Rs		-9.41	-6.31	8.61	-0.02